Malaysian Study indicates That Wharton's Jelly derived Mesenchymal Stem Cells have shown promise in treating a variety of diseases clinically
A Malaysian mesenchymal stem cell review study, "Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells" was led by Dr LL Liau from Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, 56000 Kuala Lumpur, Malaysia (Curr Res Transl Med. 2020). According to the study's conclusion: WJ-MSCs (Wharton Jelly Mesenchymal Stem Cells) have many advantages compared to MSCs (mesenchymal stem cells) from adult tissues. The discrepancies in the WJ-MSC characteristics reported in the above studies might have arisen from differences in cell isolation site and technique and cell culture procedure. Even though WJ-MSCs are safe and efficacious for treating certain diseases, most of the clinical studies/trials reported thus far do not provide sufficient evidence to support its routine use in the clinic. What are Mesenchymal Stem Cells? There are mainly two types of naturally occurring stem cells found in a human body, Hem...